Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Enzo Life Sciences LEADING LIGHT Sclerostin-LRP Interaction Screening System (1x96wells)
Supplier: Enzo Life Sciences ENZ610030001
The LEADING LIGHT Sclerostin Screening System is a 1x96 well plate assay based on Sclerostin–LRP interaction. This system contains engineered LRP5-alkaline phosphatase (ALP) and human Sclerostin immobilized in a multi-well plate. LRP5-alkaline phosphatase binds to Sclerostin coated on the bottom of the well and is detected by the activity of alkaline phosphatase remaining after a washing step. This system can be used for drug screening to identify small molecule compounds, antibodies, DNA aptamers and peptides capable of modulating sclerostin-LRP interaction. Alternative name: Sclerostin-LRP binding kit, SOST. Assay Time: 2.5 hours. Applications: FUNC, Chemiluminescence, HTS . Species reactivity: Human .
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?